A Belgian consensus on sotatercept for the treatment of pulmonary arterial hypertension.

Autor: Vachiéry JL; Department of Cardiology, Pulmonary Vascular Diseases and Heart Failure Clinic, Hôpital Universitaire de Bruxelles Erasme, Brussels, Belgium., Belge C; Clinical Department of Respiratory Diseases, University Hospitals of Leuven and Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Leuven, Belgium.; Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven - University of Leuven, Leuven, Belgium., Cools B; Department of Pediatrics, Pediatric Cardiology, University Hospitals of Leuven, Leuven, Belgium.; Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium., Damen A; Belgische Patiëntenvereniging voor Pulmonale Hypertensie (P.H. België), Hamme, Belgium., Demeure F; Department of Cardiology, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium., De Pauw M; Department of Cardiology, Ghent University Hospital, Ghent, Belgium., Dewachter C; Department of Cardiology, Pulmonary Vascular Diseases and Heart Failure Clinic, Hôpital Universitaire de Bruxelles Erasme, Brussels, Belgium., De Wolf D; Department of Pediatric Cardiology of Ghent, University Hospital, Ghent, Belgium.; Department of Pediatric Cardiology of Brussels, University Hospital, Jette, Belgium., Gabriel L; Department of Cardiology, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium., Godinas L; Clinical Department of Respiratory Diseases, University Hospitals of Leuven and Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Leuven, Belgium.; Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven - University of Leuven, Leuven, Belgium., Guiot J; Department of Respiratory Diseases, University Hospital of Liège, Liège, Belgium.; GIGA-I3 Research Group, Laboratory of Respiratory Medicine, Interstitial and Vascular Lung Diseases Unit, University of Liège, Liège, Belgium., Haine S; Department of Cardiology, Antwerp University, Edegem, Belgium.; Department of Genetics, Pharmacology and Physiopathology of Heart, Blood Vessels and Skeleton, Faculty of Medicine, University of Antwerp, Antwerp, Belgium., Leys M; Department of Respiratory Medicine, AZ Groeninge, Kortrijk, Belgium., Meysman M; Department of Medicine, Respiratory Division, Universitair Ziekenhuis Brussel, Brussels, Belgium., Pouleur AC; Cardiovascular Department, Cliniques universitaires Saint-Luc, Brussels, Belgium., Ruttens D; Department of Pulmonary Medicine, Ziekenhuis Oost-Limburg (ZOL), Genk, Belgium.; Faculty of Medicine and Life Science, Hasselt University, Hasselt, Belgium., Vandecasteele E; Department of Cardiology, Ghent University Hospital, Ghent, Belgium., Vansteenkiste W; Belgische Patiëntenvereniging voor Pulmonale Hypertensie (P.H. België), Hamme, Belgium., Weber T; Department of Respiratory Disease, Hôpital de la Citadelle, Liège, Belgium., Wirtz G; Department of Respiratory Diseases, Centre Hospitalier de Luxembourg, Luxembourg city, Luxembourg., Delcroix M; Clinical Department of Respiratory Diseases, University Hospitals of Leuven and Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Leuven, Belgium.; Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven - University of Leuven, Leuven, Belgium.

Publikováno v: Acta cardiologica [Acta Cardiol] 2024 Oct 08, pp. 1-6. Date of Electronic Publication: 2024 Oct 08.

Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients

Autor: Collen, C. ^*, Christian, N., Schallier, D., Meysman, M., Duchateau, M., Storme, G., De Ridder, M.

Publikováno v: In Annals of Oncology October 2014 25(10):1954-1959

Peak Inspiratory Flow for Screening of Inspiratory Muscle Weakness in Neuromuscular Disease.

Autor: Hanon S; Respiratory Division, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090, Brussels, Belgium. shane.hanon@uzbrussel.be., Verbanck S; Respiratory Division, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090, Brussels, Belgium., Stylemans D; Respiratory Division, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090, Brussels, Belgium., Meysman M; Respiratory Division, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090, Brussels, Belgium., Vanderhelst E; Respiratory Division, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090, Brussels, Belgium.

Publikováno v: Lung [Lung] 2023 Jun; Vol. 201 (3), pp. 321-323. Date of Electronic Publication: 2023 Apr 13.

Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography ( 18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC)

Autor: Decoster, L., Schallier, D., Everaert, H., Nieboer, K., Meysman, M., Neyns, B., De Mey, J., De Grève, J.

Publikováno v: In Lung Cancer 2008 62(1):55-61

Effects of formoterol (Oxis® Turbuhaler®) and ipratropium on exercise capacity in patients with COPD

Autor: LIESKER, J.J.W., VAN DE VELDE, V., MEYSMAN, M., VINCKEN, W., WOLLMER, PER, HANSSON, L., KERSTJENS, H.A.M., QVINT, U., PAUWELS, R.A.

Publikováno v: In Respiratory Medicine August 2002 96(8):559-566